ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma

NCT06588660 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Study terminated due to end of funding.

Conditions

Recurrent Multiple Myeloma
Refractory Multiple Myeloma

Interventions

BIOLOGICAL: Vevoctadekin
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
OTHER: Medical Chart Review
DRUG: Teclistamab
PROCEDURE: Biospecimen Collection

Sponsor

University of Washington

Collaborators

[object Object]